Format

Send to

Choose Destination
See comment in PubMed Commons below
Int J Gynecol Cancer. 2012 May;22 Suppl 1:S35-40. doi: 10.1097/IGC.0b013e318251ccaa.

The quest for ovarian cancer screening biomarkers: are we on the right road?

Author information

1
University of Pittsburgh, Pittsburgh, PA, USA. lokshina@pitt.edu

Abstract

Recent discoveries in the field of biomarkers for screening and early detection of ovarian cancer (OC) identified current needs for biomarkers capable of recognizing preclinical disease. The suggested approaches are (1) development of highly analytically sensitive CA 125 assays capable of detecting CA 125 released from small cancerous and preneoplastic lesions; (2) identification of biomarkers effective in CA 125-negative cases; and (3) performing biomarker discovery in samples obtained from patients with prophylactic bilateral salpingo-oophorectomy with pathologically confirmed preneoplastic lesions, or in appropriate animal models of ovarian cancer.

PMID:
22543919
DOI:
10.1097/IGC.0b013e318251ccaa
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Wolters Kluwer
    Loading ...
    Support Center